Insider Transactions Reported by 16 Insiders of Oncternal Therapeutics, Inc.

Location
San Diego, CA

There are no Buy or Sell transactions made by insiders since 05 Jan 2025

Oncternal Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JAMES B. BREITMEYER Chief Executive Officer, Director $325,311 14 Feb 2024
HALE DAVID F Director $282,989 20 Jun 2024
Robert Wills Director $89,613 20 Jun 2024
RICHARD G. VINCENT Chief Financial Officer $73,066 14 Feb 2024
Salim Yazji Chief Medical Officer $63,816 14 Feb 2024
Gunnar F. Kaufmann Chief Scientific Officer $46,994 12 Jun 2023
Chase C. Leavitt General Counsel/Secretary $42,048 14 Feb 2024
Rajesh Krishnan Cto/Cso $21,838 14 Feb 2024
Jill DeSimone Director 20 Jun 2024
KISNER DANIEL L Director 20 Jun 2024
Xin Nakanishi Director 28 Jun 2023
CHARLES THEUER Director 20 Jun 2024
MICHAEL G. CARTER Director 20 Jun 2024
ROSEMARY MAZANET Director 20 Jun 2024
Jinzhu Chen PhD Director 16 Jun 2022
WILLIAM R. LARUE Director 20 Jun 2024

Recent Insider Transactions by Companies or Individuals for Oncternal Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.